Relationship of the American heart association's impact goals (Life's Simple 7) with risk of chronic kidney disease: Results from the atherosclerosis risk in communities (ARIC) cohort study

Journal of the American Heart Association

Volumn 5, Issue 4, 2016, Pages

  Rebholz, Casey M ^a,b   Anderson, Cheryl A M ^a,c   Grams, Morgan E ^b,d   Bazzano, Lydia A ^e   Crews, Deidra C ^b,d   Chang, Alex R ^f   Coresh, Josef ^a,b   Appel, Lawrence J ^a,b,d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TULANE UNIVERSITY   (United States)

^f GEISINGER HEALTH SYSTEM   (United States)

Author keywords

Epidemiology; Kidney; Lifestyle; Prevention; Risk factors

Indexed keywords

ADULT; AFRICAN AMERICAN; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CHOLESTEROL INTAKE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIETARY FIBER; DIETARY INTAKE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FISH; FRUIT; GLUCOSE BLOOD LEVEL; HUMAN; LIFE SIMPLE 7; MALE; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SMOKING; SODIUM RESTRICTION; SUGAR-SWEETENED BEVERAGE; SYSTOLIC BLOOD PRESSURE; TREND STUDY; VEGETABLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; HEALTH PROMOTION; INCIDENCE; MEDICAL SOCIETY; MIDDLE AGED; MOTIVATION; RENAL INSUFFICIENCY, CHRONIC; UNITED STATES;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; FEMALE; GOALS; HEALTH PROMOTION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84995678237     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.116.003192     Document Type: Article

References (28)

1. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD; American Heart Association Strategic Planning Task F, Statistics C. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation. 2010;121:586-613.
2. Sacco RL. The new American Heart Association 2020 goal: achieving ideal cardiovascular health. J Cardiovasc Med (Hagerstown). 2011;12:255-257.
3. American Heart Association Nutrition Committee, Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, Karanja N, Lefevre M, Rudel L, Sacks F, Van Horn L, Winston M, Wylie-Rosett J. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006;114:82-96.
4. US Department of Health and Human Services and US Department of Agriculture, 2005. 6th Edition, Washington, DC: U.S. Government Printing Office, January 2005.
5. Johnson RK, Appel LJ, Brands M, Howard BV, Lefevre M, Lustig RH, Sacks F, Steffen LM, Wylie-Rosett J; American Heart Association Nutrition Committee of the Council on Nutrition PA, Metabolism, the Council on E, Prevention. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation. 2009;120:1011-1020.
6. Fretts AM, Howard BV, McKnight B, Duncan GE, Beresford SA, Mete M, Zhang Y, Siscovick DS. Life's Simple 7 and incidence of diabetes among American Indians: the Strong Heart Family Study. Diabetes Care. 2014;37:2240-2245.
7. Kronish IM, Carson AP, Davidson KW, Muntner P, Safford MM. Depressive symptoms and cardiovascular health by the American Heart Association's definition in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. PLoS One. 2012;7:e52771.
8. Kulshreshtha A, Vaccarino V, Judd SE, Howard VJ, McClellan WM, Muntner P, Hong Y, Safford MM, Goyal A, Cushman M. Life's Simple 7 and risk of incident stroke: the reasons for geographic and racial differences in stroke study. Stroke. 2013;44:1909-1914.
9. Thacker EL, Gillett SR, Wadley VG, Unverzagt FW, Judd SE, McClure LA, Howard VJ, Cushman M. The American Heart Association Life's Simple 7 and incident cognitive impairment: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. J Am Heart Assoc. 2014;3:e000635 doi: 10.1161/JAHA.113.000635.
10. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52:1527-1539.
11. Muntner P, Judd SE, Gao L, Gutierrez OM, Rizk DV, McClellan W, Cushman M, Warnock DG. Cardiovascular risk factors in CKD associate with both ESRD and mortality. J Am Soc Nephrol. 2013;24:1159-1165.
12. Ricardo AC, Anderson CA, Yang W, Zhang X, Fischer MJ, Dember LM, Fink JC, Frydrych A, Jensvold NG, Lustigova E, Nessel LC, Porter AC, Rahman M, Wright Nunes JA, Daviglus ML, Lash JP; Investigators CS. Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2015;65:412-424.
13. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129:687-702.
14. Lustgarten JA, Wenk RE. Simple, rapid, kinetic method for serum creatinine measurement. Clin Chem. 1972;18:1419-1422.
15. Parrinello CM, Grams ME, Couper D, Ballantyne CM, Hoogeveen RC, Eckfeldt JH, Selvin E, Coresh J. Recalibration of blood analytes over 25 years in the Atherosclerosis Risk in Communities Study: impact of recalibration on chronic kidney disease prevalence and incidence. Clin Chem. 2015;61:938-947.
16. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem. 1983;29:1075-1080.
17. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122:51-65.
18. Stevens J, Metcalf PA, Dennis BH, Tell GS, Shimakawa T, Folsom AR. Reliability of a food frequency questionnaire by ethnicity, gender, age and education. Nutr Res. 1996;16:735-745.
19. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; Chronic Kidney Disease Epidemiology Collaboration. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.
20. Grams ME, Rebholz CM, McMahon B, Whelton S, Ballew SH, Selvin E, Wruck L, Coresh J. Identification of incident CKD stage 3 in research studies. Am J Kidney Dis. 2014;64:214-221.
21. Cuzick J. A Wilcoxon-type test for trend. Stat Med. 1985;4:87-90.
22. Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ. Plasma lipids and risk of developing renal dysfunction: the Atherosclerosis Risk in Communities study. Kidney Int. 2000;58:293-301.
23. Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S. Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. Kidney Int. 2002;62:1743-1749.
24. Keane WF, Tomassini JE, Neff DR. Lipid abnormalities in patients with chronic kidney disease. Contrib Nephrol. 2011;171:135-142.
25. Khedr A, Khedr E, House AA. Body mass index and the risk of progression of chronic kidney disease. J Ren Nutr. 2011;21:455-461.
26. de Boer IH, Katz R, Fried LF, Ix JH, Luchsinger J, Sarnak MJ, Shlipak MG, Siscovick DS, Kestenbaum B. Obesity and change in estimated GFR among older adults. Am J Kidney Dis. 2009;54:1043-1051.
27. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144:21-28.
28. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004;65:1870-1876.